Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: A randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy-Reference-Cited by-同舟云学术

Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: A randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy

Published:2013-06 Issue:3 Volume:22 Page:263-267
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Hojo Takashi,Kinoshita Takayuki,Imoto Shigeru,Shimizu Chikako,Isaka Hirotsugu,Ito Hiroki,Imi Kentaro,Wada Noriaki,Ando Masashi,Fujiwara Yasuhiro

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference18 articles.

1. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18;Wolmark;J Natl Cancer Inst Monogr,2001

2. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial;Smith;J Clin Oncol,2005

3. Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative “Arimidex” Compared to Tamoxifen (PROACT) trial;Cataliotti;Cancer,2006

4. Preoperative treatment of postmenopausal breast cancer patients with letrozole: a randomized double-blind multicenter study;Eiermann;Ann Oncol,2001

5. Phase 11 study to define safety and efficacy of exemestane as preoperative therapy for postmenopausal patients with primary breast cancer – final results of the German Neoadjuvant Aromasin Initiative (GENARI);Krainick,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant Therapy: Current Landscape and Future Horizons for ER-Positive/HER2-Negative and Triple-Negative Early Breast Cancer;Current Treatment Options in Oncology;2024-08-15

2. Neoadjuvant endocrine treatment in hormone receptor-positive breast cancer: Does it result in more breast-conserving surgery?;Breast Cancer Research and Treatment;2024-01-24

3. Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study;Breast Cancer Research and Treatment;2023-04-03

4. Role of Exemestane in the Treatment of Estrogen-Receptor-Positive Breast Cancer: A Narrative Review of Recent Evidence;Advances in Therapy;2022-01-06

5. Controversies in Breast Cancer Surgery;Surgical Clinics of North America;2021-12